StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report sent to investors on Friday. The brokerage issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
Shares of CALA stock opened at $0.05 on Friday. Calithera Biosciences has a 12-month low of $0.00 and a 12-month high of $0.13. The firm has a 50-day moving average price of $0.02 and a 200 day moving average price of $0.02.
Calithera Biosciences Company Profile
Read More
- Five stocks we like better than Calithera Biosciences
- Business Services Stocks Investing
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- 3 Fintech Stocks With Good 2021 Prospects
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- How to Calculate Return on Investment (ROI)
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.